Abstract:Background Enzyme matrix metalloproteinase-9 is a member of the matrix metalloproteinase family, which is critical to normal tissue remodelling during embryogenesis and wound healing. In patients with endometriosis, increased expression and activity of matrix metalloproteinase-9 have been observed in ectopic endometrium, but the plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 in patients with endometriosis and their relation to disease severity have not been clear. The aim of the study was to investigate the concentrations of matrix metalloproteinase-9 in plasma and peritoneal fluid of patients with endometriosis.Methods A prospective case-control study was conducted in Jinan Military General Hospital between January 2010 and December 2013. Fifty patients with proven endometriosis and 26 endometriosis-free controls were enrolled in this study. Patients with endometriosis were evaluated and divided into moderate/severe endometriosis group (stage I-II, n=26) and minimal/mild endometriosis group (stage III-IV, n=24) according to the revised criteria of the American Society for Reproductive Medicine. Blood samples and peritoneal fluid were obtained from both patients and controls. Matrix metalloproteinase-9 was measured using enzyme-linked immunosorbent assay in plasma and peritoneal fluid. The concentration of matrix metalloproteinase-9 between different groups was compared and its correlation to disease severity was analysed.Results Plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 in patients with endometriosis were higher than that in controls. In addition, those patients with moderate/severe endometriosis had significantly higher plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 compared to those with minimal/mild endometriosis. Matrix metalloproteinase-9 concentrations in plasma and peritoneal fluid were both positively correlated with severity of endometriosis and plasma matrix metalloproteinase-9 concentrations had a positive correlation with peritoneal fluid matrix metalloproteinase-9 concentrations in patients with endometriosis.Conclusions Increased concentrations of plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 appear to be associated with disease severity of endometriosis and may serve as an alternative biomarker to determine disease severity of endometriosis.

[Expressions of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Ectopic and Eutopic Endometrium].

Research on the Expression of KISS-I/MMP-9 in Ectopic and Eutopic Endometrium from Women with Endometriosis and Its Biological Significances

[Expression of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinases-1 Mrna in the Endometrium During Mid- Luteal Phase in Women with Unexplained Infertility].

Expression and Significance of MMP-9 and TIMP-1 in Endometriosis

Expression of MMPs/TIMP in Endometriosis

Expression of MMP9,TIMP1,VEGF in Ectopic and Eutopic Endometrium in Patients with Endometriosis

Expression of Vascular Cell Adhesion Molecule 1 and Intercellular Adhesion Molecule 1 in Endometrium and Serum in Endometriosis

[Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis].

Expression and Significance of TLR3 in Eutopic and Ectopic Endometrium from Women with Endometriosis

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.

Real-time PCR in Research of Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase in Endometriosis

Idiosyncracy of Eutopic Endometrium in Patients with Endometriosis

The Expression of Matrirx Metalloproteinase and Tissue Inhibitor of Metallo-proteinase in Endometrial Child Care

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Expression of Survivin and MMP-9 in Eutopic Endometrium of Patients with Endometriosis

The expression and clinical significance of matrix metalloproteinase inhibitor-RECK in endometriosis

Expression and Significance of HGF,c-Met and MMP-2 in the Eutopic Endometrium of Endometriosis

[Expression of DNMT1, DNMT3a, and DNMT3b in Eutopic Endometrium].

[The Effect of the Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Protein on the Window Phase of Endometrial Implantation in Unexplained Infertillie Women]

The Plasma and Peritoneal Fluid Concentrations of Matrix Metalloproteinase-9 Are Elevated in Patients with Endometriosis

Expression of ER and PR in Ectopic and Eutopic Endometrium in Patients with Endomtriosis